This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
MACAU, July 20, 2018 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq:MLCO), a developer, owner and operator of casino gaming and entertainment casino resort facilities in Asia, today announces that it will furnish its unaudited financial results for the second quarter of 2018 on Form 6-K with the U.S. Securities and Exchange Commission (“SEC”) on Tuesday, July 24, 2018, to be followed by a conference call on the same day at 8:30 a.
MLCO 0200 MDEVF
SINGAPORE (July 20): Asian gaming-related stocks including Genting Singapore may move ahead of a vote on a casino bill in the Upper House of the Japanese parliament.
2282 SCHYF WYNMF MCHVF 0200 GXYEF GXYYY GIGNY 0880 SJMHY MDEVF 1128 0027 G13 6425 MCHVY 1928 GIGNF SJMHF SCHYY UETMF WYNMY
MACAU, June 15, 2018 (GLOBE NEWSWIRE) -- The grand opening of Morpheus by Melco Resorts & Entertainment Limited, was celebrated today with a host of distinguished guests and partners in Macau. The opening ceremony was attended by the Honorable Mr. Chui Sai On, Chief Executive of the Macau SAR and Mr. Ho Hau Wah, Vice-Chairman of the Chinese People’s Political Consultative Conference and officiating guests.
MLCO 0200 MDEVF
Hong Kong stocks closed moderately higher on Monday ahead of a historic US-North Korea summit that investors hope might lead to peace on the Korean peninsula.
SWRAY GELYF SJMHY MDEVF 0175 1128 PXGYF 1928 SWRBF ALBHF 2282 SWRBY SCHYF WYNMF MCHVF GELYY 0200 0880 506186 MCHVY GLXYENT 0700 SJMHF SWRAF SCHYY WYNMY
SJM Holdings, the Macau gaming operator owned by the family of casino mogul Stanley Ho, posted its biggest intra-day gain in over six years after US broker Goldman Sachs raised its target price to reflect the opening of its new flagship property, the Grand Lisboa Palace in mid-2019.
2282 SCHYF WYNMF MCHVF 0200 GXYEF GXYYY 0880 SJMHY MDEVF 1128 0027 MCHVY 1928 SJMHF SCHYY WYNMY
MACAU, May 03, 2018 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq:MLCO) (“Melco” or the “Company”), a developer, owner and operator of casino gaming and entertainment casino resort facilities in Asia, today reported its unaudited financial results for the first quarter of 2018.
MLCO 0200 MDEVF
MACAU, April 26, 2018 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq:MLCO), a developer, owner and operator of casino gaming and entertainment casino resort facilities in Asia, today announces that it will furnish its unaudited financial results for the first quarter of 2018 on Form 6-K with the U.S. Securities and Exchange Commission (“SEC”) on Thursday, May 3, 2018, to be followed by a conference call on the same day at 8:30 a.
MLCO 0200 MDEVF
China’s rising influence and hopes to securing an economic beachhead into the European Union through Greece now has a second approach – the nearby island of Cyprus, in a key geopolitical position between Europe, Asia, the Middle East and Africa.
MACAU, April 23, 2018 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment (Nasdaq:MLCO) (“Melco”), has partnered with digital entertainment platform Garena to host the 2018 League of Legends Master Series (LMS) Spring Final at Studio City Macau. Realizing Melco’s mission to shape the future of entertainment, the LMS tournament was held in Macau yesterday for the first time as one of the enclave’s largest eSports events before an audience of 2,000.
MLCO 0200 MDEVF
The Oakmark International Small Cap Fund declined 3.4% for the quarter ended March 31, 2018, underperforming the MSCI World ex U.S. Small Cap Index, which declined 0.5% for the same period.
WCAGY FINGF DGNYF GEC GE GNE BCKIF DGNTY 0200 WRCDF MDEVF BCKIY
The billionaire owner of Hong Kong’s Melco International Development said he’s going ahead with a planned launch of a casino on Cyprus and will open a temporary facility this year to get it rolling.
REVENUES generated by the City of Dreams Manila grew by a third in 2017, following an improvement across all gaming and non-gaming segments within the integrated resort and casino for the year.
PSKXF PHSXY PSE 0200 MDEVF
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to HKEX:0200 / Melco International Development Ltd on message board site Silicon Investor.
|UCMP Unicomp, Unibol G02000|